Effects of Pre-Existing Comorbidities on Outcomes in Patients with Chronic Subdural Hematoma.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 06 08 2018
revised: 23 10 2018
accepted: 26 10 2018
pubmed: 9 11 2018
medline: 23 2 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

The number of patients with chronic subdural hematoma (CSDH) showing comorbidities and/or impaired activities of daily living (ADL) before the onset of CSDH has increased with the recent aging of society. The purposes of this study were to evaluate ADL worsening by comparing premorbid ADL and ADL at discharge and to investigate the effects of pre-existing comorbidity-related clinical factors on the outcomes. A total of 570 patients with CSDH admitted from 2006 to 2016 were studied retrospectively. Clinical factors, including pre-existing comorbidities, related to outcomes were identified by multivariate analysis. A variation of the modified Rankin Scale (mRS) using 5 united categories of mRS scores 0/1, 2, 3/4, 5, and dead was used for evaluation of ADL. Of 570 patients, 390 (68.4%) had pre-existing comorbidities and 120 (21.1%) showed premorbid impaired ADL (mRS scores 2 and worse). Considering pre-existing impaired ADL, ADL deteriorated after CSDH in 92 patients (16.1%), whereas ADL impairment at discharge was found in 173 patients (30.4%). Comorbidities related to ADL deterioration on multivariate analysis were hemodialysis and chronic heart failure. Antithrombotic use for cardiovascular diseases was a predictor of acute-on-chronic subdural hematoma, which was the sole common predictor for ADL deterioration and the occurrence of surgical complications. In patients with CSDH, pre-existing comorbidity-linked factors related to outcomes were hemodialysis, chronic heart failure, and antithrombotic use. Patients with acute-on-chronic subdural hematoma with these factors should be regarded as a high-risk group.

Identifiants

pubmed: 30408607
pii: S1878-8750(18)32483-5
doi: 10.1016/j.wneu.2018.10.176
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e924-e932

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Hideki Atsumi (H)

Department of Neurosurgery, Tokai University, Kanagawa, Japan.

Takatoshi Sorimachi (T)

Department of Neurosurgery, Tokai University, Kanagawa, Japan. Electronic address: sorimachi@tokai-u.jp.

Yumie Honda (Y)

Department of Neurosurgery, Tokai University, Kanagawa, Japan.

Azusa Sunaga (A)

Department of Neurosurgery, Tokai University, Kanagawa, Japan.

Mitsunori Matsumae (M)

Department of Neurosurgery, Tokai University, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH